China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective, Openlabel, Multicenter Clinical Study of Dasatinib as Firstline Therapy for Pediatric Chronic Myeloid Leukemia in Chronic Phase'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136138
Registration Time: 2026/11/05
Type: Interventional study
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College.
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342571
Published by HT Digital Content Services with permission from Health Daily Digest....